performs the all planning, implementation of plans as part of marketing management functions. My internship program instigated from 26, September, 2010 to 25, December, 2010 and during this period, I was assigned to do the project work on the topic Generic Shifting Analysis by my onsite supervisor. I was under the direct supervision of Mr. Dipak Kumar Saha, Senior Manager, PMD, Square Pharmaceuticals Limited and Mr. Anup Chowdhury, Assistant Professor, BRAC Business School, BRAC University for my internship
Words: 23245 - Pages: 93
The pharmaceutical industry has had to adjust their marketing strategy due to the 1984 Food and Drug Administration (FDA) legislation regarding drug patent protection. Traditional market strategy has also been affected by the changing face of the consumer. Drug companies have begun advertising to consumers. In the past, marketing strategy centered on marketing to doctors. The doctors were provided samples which they made available to patients. The nonmarket environment has affected the efficiency
Words: 391 - Pages: 2
players; 1000 smaller companies - focus: pipeline – new drugs in the process of development - 15% of sales into R&D - generics: 20-30% decrease in price after patent expiration - GENERIC DRUG COMPANIES: o majority of revenues from selling generic drugs + generic active pharmaceutical ingredients (APIs) o sell packed version of the drug under own name or o sell generic APIs to other pharmaceuticals – package and sell o strict regulatory approval o success: low-cost production
Words: 281 - Pages: 2
GCC Pharmaceutical Industry March 31, 2013 Alpen Capital was awarded the “Best Research House” at the Banker Middle East Industry Awards 2011 GCC Pharmaceutical Sector | March 31, 2013 Page | 2 Table of Contents 1. 1.1. 1.2. 1.3. 1.4. EXECUTIVE SUMMARY............................................................................ 6 Scope of the Report .................................................................................. 6 Key Growth Drivers ........................
Words: 27542 - Pages: 111
Company Name : Abbott India Assignment 2- Overview of the Industry (a) Degree of competitiveness in the industry; The Indian Pharmaceutical sector is highly fragmented with more than 20,000 registered units. It has expanded drastically in the last two decades. The leading 250 pharmaceutical companies control 70% of the market with market leader holding nearly 7% of the market share. It is an extremely fragmented market with severe price competition and government price control. The pharmaceutical
Words: 1006 - Pages: 5
representatives such as education, samples, office support, and patient resources can increase brand recognition and influence prescribing. This leads to patients being influenced to spend more money on the brand name drugs, rather than the cheaper generic versions that work exactly the same. References Insert References Here. Place the cursor at the beginning of this line, and then, on the CiteWrite menu, click Format, Write Bibliography. For more help with your references, click Start, Programs
Words: 276 - Pages: 2
conditions of general environment. In pharmaceutical industry we have two kind of medications which are generic or innovative. Innovative pharmaceutical industry success depends on the patent protection in the industry. For example, in United States innovative industry can have 10 to 12 years of patent protection life from the time that product is for sale in the market. Success of the generic pharmaceuticals which are bioequivalent to innovative pharmaceutical is also related to the political
Words: 1493 - Pages: 6
differentiation and product diversification. The third scenario is driven by International Organisations which achieve a political consensus to enlarge access to ARV drugs through broader international financing and a systematic opening of the market to generics. Résumé Face à une situation de marché instable où le contexte politique est primordial, nous proposons une analyse en trois parties. Dans la première partie une esquisse de la chronologie des événements montre que l’évolution des prix des
Words: 12551 - Pages: 51
Eli Lily & Co History, Development, and Growth of the Company Eli Lilly & Company was founded in 1876 by Colonel Eli Lilly. During the 1880’s Lilly was one of the first companies to invest in Pharmaceutical research by hiring an actual pharmaceutical chemist. In the 1920’s Lilly collaborated on a research effort to purify and isolate insulin for the treatment of diabetes, a fatal disease at that time. This effort resulted in the world’s first commercially available insulin product in 1923
Words: 3703 - Pages: 15
at work Annual Report 2009-10 Contents Management Discussion and Analysis ............................. 01 Directors’ Report ....................... 26 Historical Performance .............. 29 Key Performance Indicators ....... 30 Corporate Information .............. 32 Auditors’ Report ........................ 36 Balance Sheet ............................ 40 Profit and Loss Account ............. 41 Cash Flow Statement ................. 42 Statement Relating to Subsidiary Companies .......
Words: 41744 - Pages: 167
